Operating cash flow exceeded net income by 2.25x in 2026Q2, but FCF turned negative at -$121.5M due to CapEx/Revenue of 17.8%, highlighting erratic capital intensity and working capital outflows of -$189M.
STMicroelectronics N.V. (STM) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 2.26B | 2.15B | 2.96B | 5.99B | 5.2B | 3.06B | 2.09B | 1.87B | 1.84B | 1.68B | 1.04B | 846M | 715M | 366M | 612M | 880M | 1.79B | 152.67B | -16.52B | 2.19B | 2.49B | 1.8B | 2.34B | 1.92B | 1.71B | 2.05B | 2.43B | 1.47B | 1.01B | 983.79M | 980.67M |
| Operating CF Margin % | - | 18.18% | 22.35% | 34.66% | 32.25% | 23.98% | 20.48% | 19.55% | 19.09% | 20.09% | 14.96% | 12.27% | 9.66% | 4.53% | 7.21% | 9.04% | 17.34% | 1794.04% | -167.87% | 21.88% | 25.28% | 20.24% | 26.74% | 26.53% | 27.11% | 32.28% | 31.12% | 29.06% | 23.84% | 24.48% | 23.79% |
| Operating CF Growth % | 42.46% | -27.42% | -50.52% | 15.19% | 70% | 46.2% | 12.04% | 1.25% | 10.02% | 60.79% | 23.29% | 18.32% | 95.36% | -40.2% | -30.45% | -50.95% | -98.82% | 1024.06% | -855.12% | -12.16% | 38.54% | -23.23% | 21.98% | 12.08% | -16.52% | -15.62% | 65.51% | 45.11% | 2.92% | 0.32% | 18.85% |
| Net Income | 465M | 180M | 1.56B | 4.21B | 3.97B | 2.01B | 1.11B | 1.03B | 1.29B | 802M | 165M | 104M | 128M | -500M | -1.16B | 155M | 840M | -1.59B | -786M | -477M | 782M | 266M | 601M | 253M | 429M | 257.07M | 1.45B | 547.25M | 411.12M | 406.55M | 625.54M |
| Depreciation & Amortization | 585.93M | 1.85B | 1.76B | 1.56B | 1.22B | 1.04B | 923M | 854M | 791M | 650M | 696M | 736M | 811M | 910M | 1.07B | 1.28B | 1.24B | 243.05B | 171.35B | 1.41B | 1.77B | 1.94B | 1.84B | 1.61B | 1.47B | 1.4B | 1.14B | 806.79M | 704M | 608.12M | 535.91M |
| Stock-Based Compensation | -18M | 193M | 222M | 236M | 215M | 221M | 155M | 145M | 121M | 66M | 42M | 41M | 39M | 26M | 11M | 29M | 34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 178M | 17M | 124M | 19M | 3M | 45M | -8M | 25M | 284M | 33M | -38M | -113M | -164M | -48M | -80M | 47M | 120M | 1.98B | -18.45B | -148M | -74M | -31M | -6M | -131M | 14M | -82.74M | -4.54M | 28.71M | 34.33M | -3.16M | 0 |
| Other Non-Cash Items | 1.47B | 51M | -203M | -113M | -68M | -112M | -106M | -90M | -233M | 431M | 240M | 39M | -215M | 57M | 544M | -545M | -669M | -91.21B | -168.62B | 1.34B | 77M | 91M | 52M | 251M | 21M | 1K | 12.34M | 7.18M | 13.64M | 16.62M | -1.63M |
| Working Capital Changes | -421.68M | -143M | -495M | 78M | -130M | -145M | 21M | -99M | -409M | -300M | -58M | 42M | 119M | -79M | 226M | -85M | 229M | 447M | -19M | 62M | -60M | -472M | -142M | -61M | -251M | 144.7M | -165.39M | 79.35M | -150.56M | -44.35M | -179.15M |
| Change in Receivables | -1.23B | 5M | -32M | 229M | -231M | -307M | -72M | -103M | -155M | -206M | -121M | 81M | 119M | -57M | 35M | 184M | 139M | 57.16B | -230.9B | 2M | -104M | -117M | -119M | -109M | -129M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 579M | -172M | -167M | -72M | -650M | -188M | -84M | -142M | -254M | -94M | 63M | -39M | 163M | -22M | 191M | -59M | -252M | 71.14B | -1.03B | 24M | -161M | -174M | -144M | -75M | -71M | 93.64M | -299.99M | -38.34M | -18.81M | -149.64M | -80.52M |
| Change in Payables | 140M | 83M | -35M | -238M | 240M | 95M | 161M | -14M | 4M | 141M | 68M | -46M | -70M | -139M | 148M | -384M | 212M | -30.9B | 58.05B | 19M | 36M | -71M | 128M | -8M | -21M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -1.31B | -43M | -3.74B | -5.77B | -4.59B | -1.52B | -2.04B | -1.17B | -1.21B | -1.47B | -727M | -516M | -784M | -379M | -396M | -287M | -526M | 290M | -2.42B | -1.74B | -2.75B | -1.53B | -2.13B | -1.44B | -1.37B | -1.8B | -3.57B | -1.54B | -966.25M | -1.05B | -1.12B |
| Capital Expenditures | -136.49M | -2.11B | -3.09B | -4.44B | -3.55B | -1.84B | -1.28B | -1.22B | -1.26B | -1.3B | -611M | -529M | -505M | -543M | -492M | -1.26B | -1.03B | -451M | -983M | -1.35B | -1.62B | -1.44B | -2.05B | -1.22B | 0 | -1.7B | -3.32B | -1.35B | -947.25M | -1.04B | -1.13B |
| CapEx % of Revenue | 1.04% | 17.83% | 23.27% | 25.68% | 22.01% | 14.42% | 12.55% | 12.79% | 13.07% | 15.59% | 8.76% | 7.67% | 6.82% | 6.72% | 5.79% | 12.92% | 9.99% | 5.3% | 9.99% | 13.48% | 16.43% | 16.22% | 23.4% | 16.87% | - | 26.74% | 42.46% | 26.65% | 22.3% | 25.76% | 27.3% |
| Acquisitions | -895M | 0 | 0 | 0 | 0 | 0 | -112M | -127M | -100M | 3M | -78M | -14M | 53M | 56M | -1M | -10M | -11M | -18M | -1.69B | -351M | 7M | 0 | -3M | -188M | -307M | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -454.5M | 174M | 353M | 231M | -62M | -85M | -71M | -20M | 51M | -68M | -38M | 13M | -48M | 164M | -83M | -103M | 400M | 1.16B | 0 | 319M | -1.34B | -87M | -81M | -30M | -1.06B | -1K | -249.54M | -190.29M | -19M | -16.06M | 3.12M |
| Cash from Financing | 545.74M | -1.56B | -155M | -267M | -567M | -1.31B | 348M | -343M | -122M | -106M | -439M | -560M | 262M | -388M | 135M | -529M | -876M | -513M | -67M | -296M | 132M | -178M | -1.27B | -59M | -232M | -98.11M | 1.62B | 806.04M | 352.63M | 249.06M | -59.03M |
| Debt Issued (Net) | 2.1B | -989M | 97M | 160M | 66M | -569M | 678M | 137M | 178M | 390M | -178M | -200M | 774M | -144M | 499M | -195M | -650M | -256M | 496M | -23M | 210M | -107M | -1.19B | -9M | -109M | 128M | 1.6B | 598.45M | 119.3M | 239.39M | -75.7M |
| Equity Issued (Net) | 184M | -367M | -359M | -346M | -346M | -485M | -125M | -250M | -80M | -306M | 0 | 0 | -156M | 0 | 0 | 0 | 0 | -92M | -313M | 0 | 28M | 35M | 23M | 22M | -86M | -190M | 38.17M | 230.44M | 233.33M | 9.67M | 16.67M |
| Dividends Paid | -88.77M | -321M | -288M | -223M | -212M | -205M | -168M | -214M | -216M | -214M | -251M | -350M | -354M | -346M | -355M | -332M | -219M | -158M | -250M | -269M | -107M | -107M | -107M | -71M | -36M | -35.77M | -26.6M | -22.85M | 0 | 0 | 0 |
| Share Repurchases | 184M | -367M | -359M | -346M | -346M | -485M | -125M | -250M | -80M | -306M | -3M | -4M | -156M | 0 | 0 | 0 | 0 | 0 | -313M | 0 | 0 | 0 | 0 | 0 | -115M | -233M | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.65B | 117M | 395M | 142M | -75M | -55M | -37M | -16M | -4M | 24M | -10M | -10M | -2M | 102M | -9M | -7M | -14M | -2M | -10M | 2M | 1M | 1M | 0 | -1M | -1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 1.48B | 555M | -940M | -36M | 33M | 219M | 399M | 341M | 507M | 130M | -142M | -246M | 181M | -414M | 338M | 20M | 304M | 70.17B | 474.95B | 196M | -64M | 77M | -1.05B | 436M | 123M | 143.11M | 472.62M | 722.33M | 398.6M | 150.26M | -202.15M |
| Free Cash Flow | 216.33M | -52M | -216M | 1.46B | 1.57B | 1.12B | 735M | 646M | 582M | 376M | 432M | 317M | 210M | -177M | 120M | -378M | 760M | 152.22B | -17.5B | 840M | 872M | 357M | 292M | 699M | 1.71B | 352.25M | -885.83M | 121.75M | 65.29M | -51.64M | -144.54M |
| FCF Margin % | 1.65% | -0.44% | -1.63% | 8.42% | 9.71% | 8.8% | 7.19% | 6.76% | 6.02% | 4.5% | 6.2% | 4.6% | 2.84% | -2.19% | 1.41% | -3.88% | 7.35% | 1788.74% | -177.86% | 8.4% | 8.85% | 4.02% | 3.33% | 9.66% | 27.11% | 5.54% | -11.34% | 2.41% | 1.54% | -1.28% | -3.51% |
| FCF Growth % | 197.88% | 75.93% | -114.84% | -7.02% | 39.45% | 52.79% | 13.78% | 11% | 54.79% | -12.96% | 36.28% | 50.95% | 218.64% | -247.5% | 131.75% | -149.74% | -99.5% | 969.59% | -2183.93% | -3.67% | 144.26% | 22.26% | -58.23% | -59.19% | 386.3% | 139.77% | -827.61% | 86.46% | 226.43% | 64.27% | 18.25% |
| FCF per Share | 0.23 | -0.06 | -0.23 | 1.54 | 1.72 | 1.22 | 0.80 | 0.71 | 0.64 | 0.41 | 0.49 | 0.36 | 0.24 | -0.20 | 0.14 | -0.42 | 0.83 | 173.59 | -19.63 | 0.93 | 0.87 | 0.39 | 0.32 | 0.75 | 1.92 | 0.40 | -0.96 | 0.14 | 0.08 | -0.06 | -0.17 |
| FCF Conversion (FCF/Net Income) | 0.47x | 12.92x | 1.90x | 1.42x | 1.31x | 1.53x | 1.89x | 1.81x | 1.13x | 7.69x | 8.62x | 4.83x | 5.07x | -0.73x | -0.53x | 1.35x | 2.16x | -134.99x | 21.02x | -4.59x | 3.19x | 6.76x | 3.90x | 7.59x | 3.99x | 7.98x | 1.67x | 2.68x | 2.46x | 2.42x | 1.57x |
| Interest Paid | 0 | 54M | 67M | 31M | 2M | 2M | 7M | 13M | 12M | 12M | 13M | 15M | 11M | 10M | 26M | 17M | 15M | 34M | 63M | 52M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 141M | 197M | 489M | 416M | 279M | 138M | 130M | 60M | 52M | 42M | 41M | 30M | 23M | 51M | 83M | 23M | 141M | 154M | 133M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying STM stock.
STMicroelectronics N.V. (STM) generated $2.15B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
STMicroelectronics N.V. (STM) reported negative free cash flow of $52.0M in 2025, indicating capital requirements exceeded cash from operations.
STMicroelectronics N.V. (STM) spent $2.11B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, STMicroelectronics N.V. (STM) returned $321.0M to shareholders via cash dividends and spent $367.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Persistent margin compression and demand weakness
Earnings Quality Masked by Depreciation
Operating cash flow exceeded net income by 2.25x in 2026Q2, but this gap is largely attributable to $490.6M in depreciation, suggesting earnings quality is heavily dependent on non-cash charges.
The OCF/NI ratio of 2.25 in 2026Q2, while superficially strong, is inflated by a $490.6M depreciation charge that is not a cash outflow. This pattern is consistent across the period, with OCF/NI averaging above 2.0 in most quarters, indicating that reported net income understates cash generation due to the capital-intensive IDM model. However, the negative net income in 2025Q2 and 2025Q4, where OCF remained positive, underscores that cash flow is more stable than earnings, but the reliance on D&A to bridge the gap warrants scrutiny.
Free Cash Flow Volatility Persists
Free cash flow swung from -$261M in 2025Q2 to +$155.5M in 2026Q1, but 2026Q2 turned negative again at -$121.5M, reflecting erratic capital spending and weak conversion relative to peers like TXN's 27.5% FCF margin.
The FCF margin has been negative or near zero in most quarters, with 2026Q2 at -3.5%, a stark contrast to the 27.5% FCF margin reported by Texas Instruments. This volatility is driven by lumpy capex, which ranged from $380M to $1.2B per quarter, and inconsistent operating cash flow. The recent revenue rebound has not translated into sustained FCF generation, suggesting that the company is still in a reinvestment phase or facing margin headwinds that limit cash conversion.
Capital Intensity Strains Cash Generation
CapEx as a percentage of revenue spiked to 37.0% in 2025Q4 and averaged 20.5% over the last year, far exceeding the 10-15% typical for mature peers, indicating heavy investment in growth initiatives like SiC.
The elevated capital intensity, with CapEx/Revenue reaching 37.0% in 2025Q4, suggests STM is prioritizing capacity expansion, likely for silicon carbide and 300mm wafer production. While this may position the company for future growth, it currently consumes a significant portion of operating cash flow, leaving little for shareholder returns. The negative FCF in several quarters, including 2026Q2, indicates that the investment cycle is not yet self-funding, and investors should monitor whether these investments yield the expected margin expansion.
Working Capital Drags on Cash Flow
Working capital changes were negative in seven of the last ten quarters, with 2026Q2 showing a -$189M outflow, suggesting inventory build-up or slower collections that are consuming cash.
The persistent negative working capital changes, such as -$228M in 2025Q4 and -$207M in 2024Q2, indicate that STM is investing in inventory or facing delayed receivables, which is typical during a demand trough. This trend is concerning because it suggests that even as revenue recovers, cash conversion is being held back by operational needs. The 2026Q1 positive $147M change was an anomaly, and the reversion to negative in 2026Q2 implies that working capital remains a structural drag on free cash flow.
Conservative Returns Amidst Reinvestment
Dividends totaled $74.8M in 2026Q2, while buybacks were absent, and acquisitions were minimal, reflecting a conservative capital allocation strategy that prioritizes internal investment over shareholder returns.
The company has consistently paid dividends, but the amounts are modest relative to cash flow, and buybacks have been zero in recent quarters, a shift from the $92M quarterly buybacks seen in 2024. This suggests management is preserving cash for capex and debt reduction, consistent with the low debt-to-equity ratio of 0.12%. While this approach supports balance sheet strength, it may disappoint income-focused investors, especially when FCF is negative, as in 2026Q2.
Cumulative Cash Outpaces Earnings
Over the last ten quarters, cumulative operating cash flow of $5.93B exceeded cumulative net income of $1.98B by $3.95B, indicating that earnings understate cash generation due to heavy depreciation.
The cumulative gap between OCF and net income is substantial, with OCF totaling $5.93B versus net income of $1.98B, a ratio of 3.0x. This divergence is primarily driven by cumulative depreciation and amortization of $4.19B, which is a non-cash expense. While this suggests that earnings quality is high in terms of cash backing, it also highlights the capital-intensive nature of the business, where significant reinvestment is required to maintain the asset base. Investors should recognize that this cash generation is not entirely distributable, as a large portion must be reinvested to sustain operations.
What Could Invalidate the Base Case
The cash flow statement may obscure the true cost of growth, as capitalized R&D and government grants could be smoothing earnings, while the absence of buybacks and negative FCF in 2026Q2 suggests underlying strain.
The reported operating cash flow may be flattered by the capitalization of certain R&D expenses and the timing of European government grants, which are non-operational in nature. Additionally, the lack of share repurchases in recent quarters, despite a history of buybacks, could indicate management's caution about future cash generation. If the recent revenue rebound fails to translate into positive FCF, the company may need to cut dividends or increase debt, which would contradict the current 'Healthy' balance sheet signal. Investors should monitor whether the gap between OCF and FCF narrows as capex normalizes.